These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 11085519

  • 21. Investigation of glucocorticoid-induced apoptotic pathway: processing of caspase-6 but not caspase-3.
    Miyashita T, Nagao K, Krajewski S, Salvesen GS, Reed JC, Inoue T, Yamada M.
    Cell Death Differ; 1998 Dec; 5(12):1034-41. PubMed ID: 9894610
    [Abstract] [Full Text] [Related]

  • 22. Merbarone, a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE/CED-3-like protease.
    Khélifa T, Beck WT.
    Mol Pharmacol; 1999 Mar; 55(3):548-56. PubMed ID: 10051540
    [Abstract] [Full Text] [Related]

  • 23. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
    Yu W, Simmons-Menchaca M, You H, Brown P, Birrer MJ, Sanders BG, Kline K.
    Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
    [Abstract] [Full Text] [Related]

  • 24. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP.
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [Abstract] [Full Text] [Related]

  • 25. Developmental differences in HO-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3.
    Fragoso G, Martínez-Bermúdez AK, Liu HN, Khorchid A, Chemtob S, Mushynski WE, Almazan G.
    J Neurochem; 2004 Jul; 90(2):392-404. PubMed ID: 15228596
    [Abstract] [Full Text] [Related]

  • 26. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM, Wang Y, Weber RL, Sperfslage BJ, Lou K, Crossland J, Hua DH, Perchellet JP.
    Biochem Pharmacol; 2004 Feb 01; 67(3):523-37. PubMed ID: 15037204
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of caspase or FADD function blocks proliferation but not MAP kinase-activation and interleukin-2-production during primary stimulation of T cells.
    Mack A, Häcker G.
    Eur J Immunol; 2002 Jul 01; 32(7):1986-92. PubMed ID: 12115619
    [Abstract] [Full Text] [Related]

  • 28. Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2.
    Guo H, Tittle TV, Allen H, Maziarz RT.
    Exp Cell Res; 1998 Nov 25; 245(1):57-68. PubMed ID: 9828101
    [Abstract] [Full Text] [Related]

  • 29. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 25; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 30. Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells.
    Bowie ML, Dietze EC, Delrow J, Bean GR, Troch MM, Marjoram RJ, Seewaldt VL.
    Oncogene; 2004 Nov 18; 23(54):8743-55. PubMed ID: 15467738
    [Abstract] [Full Text] [Related]

  • 31. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ, Ng LT, Lin CC.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):96-106. PubMed ID: 16054126
    [Abstract] [Full Text] [Related]

  • 32. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
    Motwani M, Delohery TM, Schwartz GK.
    Clin Cancer Res; 1999 Jul 22; 5(7):1876-83. PubMed ID: 10430095
    [Abstract] [Full Text] [Related]

  • 33. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
    Chen C, Shen G, Hebbar V, Hu R, Owuor ED, Kong AN.
    Carcinogenesis; 2003 Aug 22; 24(8):1369-78. PubMed ID: 12819184
    [Abstract] [Full Text] [Related]

  • 34. Baculovirus p35 and Z-VAD-fmk inhibit thapsigargin-induced apoptosis of breast cancer cells.
    Qi XM, He H, Zhong H, Distelhorst CW.
    Oncogene; 1997 Sep 04; 15(10):1207-12. PubMed ID: 9294614
    [Abstract] [Full Text] [Related]

  • 35. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
    Wang J, Ladrech S, Pujol R, Brabet P, Van De Water TR, Puel JL.
    Cancer Res; 2004 Dec 15; 64(24):9217-24. PubMed ID: 15604295
    [Abstract] [Full Text] [Related]

  • 36. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
    Hu H, Jiang C, Ip C, Rustum YM, Lü J.
    Clin Cancer Res; 2005 Mar 15; 11(6):2379-88. PubMed ID: 15788689
    [Abstract] [Full Text] [Related]

  • 37. Polyamines are required for activation of c-Jun NH2-terminal kinase and apoptosis in response to TNF-alpha in IEC-6 cells.
    Bhattacharya S, Ray RM, Viar MJ, Johnson LR.
    Am J Physiol Gastrointest Liver Physiol; 2003 Nov 15; 285(5):G980-91. PubMed ID: 12869386
    [Abstract] [Full Text] [Related]

  • 38. Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate.
    Asakura T, Sawai T, Hashidume Y, Ohkawa Y, Yokoyama S, Ohkawa K.
    Br J Cancer; 1999 May 15; 80(5-6):711-5. PubMed ID: 10360648
    [Abstract] [Full Text] [Related]

  • 39. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
    MacFarlane M, Cohen GM, Dickens M.
    Biochem J; 2000 May 15; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718
    [Abstract] [Full Text] [Related]

  • 40. Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
    Hughes FM, Evans-Storms RB, Cidlowski JA.
    Cell Death Differ; 1998 Dec 15; 5(12):1017-27. PubMed ID: 9894608
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.